Searched for
CINACALCET
Aurobindo Pharma, Glenmark recall products in USAurobindo, Glenmark, and Zydus are recalling pharmaceutical products in the US due to manufacturing issues. Aurobindo and Glenmark's recall...- Dr Reddy's recalls over 3.3 lakh bottles of generic medication in US: USFDADr Reddy's Laboratories is recalling over 3.3 lakh bottles of Cinacalcet tablets in the US due to manufacturing issues. The recall is due t...
- On a path to recovery: 4 small pharma stocks with an upside potential of up to 27%As the markets get jittery, select pharma stocks are back in focus. This tends to happen in volatile markets. Some of them are small and mi...
- Cipla settles case with Amgen Inc involving generic cinacalcet hydrochloride tabletsA formal stipulation of dismissal has been filed with the court and is awaiting signature by the presiding Judge, the filing added.
- A big opportunity is beginning to unlock for us in the US: Cipla'Inhaler opportunity can add to Cipla’s position in lung medicines.'
- Cipla Q3 results preview: Profit likely to rise 25-27%The company will report its quarterly numbers on Wednesday.
- Stock pick of the week: What has made Cipla a favourite of analystsDue to the recent price correction, the risk-reward ratio of Cipla has turned favourable. Despite the tough environment, the company is tak...
- Cipla to target industry-leading growth from Q2 onwards: Umang VohraIn South Africa, our private market business is up. It is growing faster than the market.
- Cipla Q1 results: Profit likely to fall 14%, US sales may take a hitCentrum expects South Africa and RoW also to remain under pressure in terms of growth and R&D spend to remain higher around 8 per cent of s...
- Stocks in the news: DHFL, IndiGo, Aurobindo Pharma, Religare and GTPL HathwayNCLT dismissed a petition by HDFC to initiate insolvency proceedings against RHC Holding.
Load More
